Pfizer CEO Albert Bourla told Fox Business on Wednesday (May 1) that the company expects to score big on “blockbuster” cancer drugs now that the COVID-19 crisis is over and the global demand for its vaccines and COVID drugs is falling.
In the interview, Bourla praised the measures as a “very good cost containment” campaign, crediting it for the “very good results” his company showed in early 2024. Pfizer is also on the verge of striking gold again with its new strategy, he said.
“Oncology, it is our new Covid,” the Pfizer CEO said. “We did what we did with Covid. We are very proud to have saved the world but it is behind us now. We want to do [it] once more and I think oncology is our best chance to do it.”
